Our data confirm that in ART-experienced patients with no signs of viral replication and with a normal CD4+ cell count, AIT was not associated with aggravation of HIV infection, an elevated risk of adverse reactions, or poor efficacy. This evidence concerns the gene CD4 and HIV infectious disease.